Green Thumb Industries (GTBIF) Shares Outstanding (2018 - 2026)
Green Thumb Industries' (GTBIF) quarterly Shares Outstanding (Entity) came in at $202.0 million in Q1 2026, down 4.73% YoY from $212.0 million in Q1 2025, and down 2.23% on a QoQ basis from $206.6 million in Q4 2025.
Green Thumb Industries (GTBIF) Shares Outstanding (2018 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 9 years of Shares Outstanding (Entity) data on file, last reported at $202.0 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) fell 4.73% year-over-year to $202.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $202.0 million (down 4.73% YoY) and the FY2025 annual result came in at $206.6 million, down 2.13% from the prior year.
- Shares Outstanding (Entity) slipped to $202.0 million in Q1 2026, from $206.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $212.0 million in Q1 2025 to a low of $202.0 million in Q1 2026.
- A 5-year average of $208.1 million and a median of $207.8 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) increased 9.9% — and 2026, when it declined 4.73%.
- Tracing GTBIF's Shares Outstanding (Entity) over 5 years: stood at $207.0 million in 2022, then rose by 1.39% to $209.9 million in 2023, then grew by 0.6% to $211.1 million in 2024, then slipped by 2.13% to $206.6 million in 2025, then retreated by 2.23% to $202.0 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $202.0 million (Q1 2026), $206.6 million (Q4 2025), and $207.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 832.44 Mn |
| 10 | Green Thumb Industries | 1.69 Bn | 1.41 Bn | 137.87 Mn | 221.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 221.02 Mn |
| Mar 31, 2026 | 230.60 Mn |
| Dec 31, 2025 | 233.87 Mn |
| Sep 30, 2025 | 231.65 Mn |
| Jun 30, 2025 | 235.84 Mn |
| Mar 31, 2025 | 236.12 Mn |
| Dec 31, 2024 | 236.83 Mn |
| Sep 30, 2024 | 236.30 Mn |
| Jun 30, 2024 | 237.42 Mn |
| Mar 31, 2024 | 236.76 Mn |
| Dec 31, 2023 | 237.93 Mn |
| Sep 30, 2023 | 239.46 Mn |
| Jun 30, 2023 | 238.00 Mn |
| Mar 31, 2023 | 237.40 Mn |
| Dec 31, 2022 | 236.71 Mn |
| Sep 30, 2022 | 237.00 Mn |
| Jun 30, 2022 | 236.78 Mn |
| Mar 31, 2022 | 235.84 Mn |
| Dec 31, 2021 | 223.19 Mn |
| Sep 30, 2021 | 226.53 Mn |